Bookmark

Add to MyYahoo RSS

Acclarent News

News on Acclarent (Ticker: JNJ) continually updated from thousands of sources around the net.

Thursday | Journal Watch

J&J Withdraws Power Morcellators

Johnson & Johnson is withdrawing its laparoscopic power morcellators from hospitals amid concerns that the devices may potentially spread undetected uterine sarcoma during fibroid removal and hysterectomy, the Wall Street Journal reports.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Thursday | TheStreet.com

Why Johnson & Johnson (JNJ) Stock Is Lower Today

The company plans to tell customers world-wide in a letter today to return the devices known as laparoscopic power morcellators, the Journal said, STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Thursday | National Public Radio

Senate Antitrust Panel Eyes Contact Lens Pricing Policies

Under "UPP," or universal pricing policies, manufacturers like Johnson & Johnson tell retailers they can't sell their contact lens below a certain price.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Jul 30, 2014

The Washington Post

J&J Pulls From Market Hysterectomy Device Tied to Cancer Spread

Johnson & Johnson is pulling from the global market a device used during hysterectomies and other uterine procedures after reports that it may spread and accelerate the growth of undetected cancer inside women.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Jul 28, 2014

Forbes.com

One Put, One Call Option To Know About for Johnson & Johnson

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Thu Jul 24, 2014

GigaOM

Johnson & Johnson partners with Organovo to consider 3D-printing living tissue

The partnership centers around using bioprinted tissue to discover new drugs. The announcement comes ahead of Organovo's commercial launch later this year.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Jul 23, 2014

The New Zealand Herald

What's best for baby?

Sharon Dowling, research and development manager for leading company Johnson & Johnson , shares her advice.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Jul 21, 2014

TheStreet.com

Johnson & Johnson (JNJ) Declares 70c Quarterly Dividend

The quarterly dividend is in line with the company's previous. The dividend is payable on Sept.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Jul 16, 2014

AmericanBankingNews.com

Johnson & Johnson Given "Neutral" Rating at Zacks

's stock had its "neutral" rating reaffirmed by Zacks in a note issued to investors on Wednesday.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Morningstar

J&J's Strong 2Q Led by Pharmaceuticals

Johnson & Johnson reported strong second-quarter results that exceeded both our and consensus expectations largely because of stronger-than-expected pharmaceutical sales.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Tue Jul 15, 2014

TheStreet.com

Johnson & Johnson Beats on EPS but Sags on a Technical Basis

The large-cap pharmaceutical company also beat on revenue and raised full-year guidance.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

AmericanBankingNews.com

Tues., July 15: Hewlett-Packard Among Stocks to Watch

WSJ's Polya Lesova joins Simon Constable on the News Hub to discuss why investors are eyeing Hewlett-Packard, Reynolds American and Johnson & Johnson stock.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Pharmaceutical Processing

J&J Second Quarter Profit Climbs 13%

Johnson & Johnson has reported earnings that climbed by 13 percent in its second quarter, and topped analysts' expectations.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Jul 14, 2014

The Motley Fool

Earnings Preview: Abbott Laboratories and Johnson & Johnson

The health care sector in general, and biotech industry in particular, have now shrugged off their earlier first quarter dip.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

AmericanBankingNews.com

Johnson & Johnson (JNJ) to Release Earnings on Tuesday

Johnson & Johnson is set to release its Q214 earnings data on Tuesday, July 15th.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Fri Jul 11, 2014

The Motley Fool

Today's Top Biotech Stocks to Watch: Johnson & Johnson and Sarepta Therapeutics

Let's take a look at today's top stories in biotech and health care. Keep an eye out for Johnson & Johnson ( Analysts are optimistic about Johnson & Johnson's second quarter earnings With J&J set to reveal second quarter earnings next Tuesday, July 15, Wall Street analysts are predicting that the company will beat consensus earnings per share of ... (more)

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Jul 09, 2014

The Motley Fool

Is Pharmacyclics the Next Celgene?

Revlimid notched label expansions for use in multiple myeloma in 2006 and mantle cell lymphoma in 2013.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Jul 07, 2014

The Motley Fool

The Dow Breaks Its Streak but Holds 17,000 as Johnson & Johnson and AT&T Rise

Yet even as nervous investors took profits after weighing the potential for future gains against the risk involved in the stock market, the Dow still managed to hang onto the 17,000 level.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Thu Jul 03, 2014

BioSpace

Johnson & Johnson Unit DePuy Synthes Whacks 400 Jobs As Part Of Reorganization

Johnson & Johnson is axing jobs but others are hiring too! Check it out! Faced with an array of challenges, the DePuy Synthes medical device unit of Johnson & Johnson JNJ -0.01% is undergoing a reorganization that will eliminate approximately 400 jobs, or less than 2% of the global DePuy workforce of 23,000 employees.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

The Jersey Journal

Family of man found dead in New Brunswick raises money for funeral

OLD BRIDGE - The family of township resident Marcin Gadkowski, who was found dead near the New Brunswick train station on Monday, is raising money for his funeral.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Micrus, OrthoClinical Diagnostics, Medical Equipment

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••